로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > HTT

HTT

요약

Name:Huntingtin
Target Synonym:Huntingtin,HD protein,HD,HTT,Huntington Disease Protein,IT15,Huntingtin (Huntington Disease),LOMARS,Huntingtin Protein
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 3 Clinical

제품 리스트 구매

제품 상태별:
제품 유형별 :
종별:
결합물별:
제품번호 제품 설명 구조 순도 특징
HTT-H51M5 Human Human HTT Protein, MBP,His Tag (MALS verified)
HTT-H51M5-structure
HTT-H51M5-sds

일부의 생물활성 데이터

HTT-H51M5-ELISA
HTT MALS images

The purity of Human HTT, MBP,His Tag (Cat. No. HTT-H51M5) is more than 85% and the molecular weight of this protein is around 62-80 kDa verified by SEC-MALS.

Synonym Name

HTT,Htt,Huntingtin

Background

Huntingtin is the protein coded for by the HTT gene. Autosomal dominant mutation in the Huntingtin (Htt) protein is the cause of Huntington’s Disease (HD). In HD, the polyglutamine (polyQ) domain  in the N-terminal sequenceof the protein is expanded beyond a threshold of 36 glutamines. mutant polyQ expansion strongly correlates in an inverse manner to disease age of onset.

Clinical and Translational Updates

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
WVE-003 WVE-003 Phase 2 Clinical Wave Life Sciences Ltd Huntington Disease Details
PTC-518 PTC-518 Phase 2 Clinical Ptc Therapeutics Inc Huntington Disease Details
Tominersen RG-6042; RO-7234292; ISIS-443139 Phase 3 Clinical Ionis Pharmaceuticals Inc, F. Hoffmann-La Roche Ltd Huntington Disease Details

This web search service is supported by Google Inc.

totop